140 related articles for article (PubMed ID: 15462261)
1. Reduction in neutrophil elastase concentration by recombinant alphal-antitrypsin (recAAT) does not alter bacterial loading in the sputum of cystic fibrosis patients.
Moore JE; Shaw A; Millar BC; Martin SL; Murphy PG; Downey DG; Ennis M; Elborn JS
Br J Biomed Sci; 2004; 61(3):146-7. PubMed ID: 15462261
[No Abstract] [Full Text] [Related]
2. Safety and efficacy of recombinant alpha(1)-antitrypsin therapy in cystic fibrosis.
Martin SL; Downey D; Bilton D; Keogan MT; Edgar J; Elborn JS;
Pediatr Pulmonol; 2006 Feb; 41(2):177-83. PubMed ID: 16372352
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil proteinases and rhDNase therapy in cystic fibrosis.
Vogelmeier C; Döring G
Eur Respir J; 1996 Nov; 9(11):2193-5. PubMed ID: 8947058
[No Abstract] [Full Text] [Related]
4. Alpha-1 Antitrypsin Therapy in Cystic Fibrosis and the Lung Disease Associated with Alpha-1 Antitrypsin Deficiency.
McElvaney NG
Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S191-6. PubMed ID: 27115956
[TBL] [Abstract][Full Text] [Related]
5. The protease-antiprotease battle in the cystic fibrosis lung.
Balfour-Lynn IM
J R Soc Med; 1999; 92 Suppl 37(Suppl 37):23-30. PubMed ID: 10472249
[No Abstract] [Full Text] [Related]
6. Secretory leukocyte protease inhibitor in cystic fibrosis.
Stromatt SC
Agents Actions Suppl; 1993; 42():103-10. PubMed ID: 8102834
[TBL] [Abstract][Full Text] [Related]
7. Proteinase 3, a potent secretagogue in airways, is present in cystic fibrosis sputum.
Witko-Sarsat V; Halbwachs-Mecarelli L; Schuster A; Nusbaum P; Ueki I; Canteloup S; Lenoir G; Descamps-Latscha B; Nadel JA
Am J Respir Cell Mol Biol; 1999 Apr; 20(4):729-36. PubMed ID: 10101005
[TBL] [Abstract][Full Text] [Related]
8. [An alpha 1-antitrypsin aerosol in the treatment of cystic fibrosis].
Ferrer Calvete J; Aznar Lucea J; Morales Marín P; Pereda Pérez A; Llopis Carles R; Ribes Koninckx C; Ferrer González P; Marco Martínez V
An Esp Pediatr; 1996 Feb; 44(2):109-11. PubMed ID: 8830566
[TBL] [Abstract][Full Text] [Related]
9. Host inflammatory responses to first isolation of Pseudomonas aeruginosa from sputum in cystic fibrosis.
Elborn JS; Cordon SM; Shale DJ
Pediatr Pulmonol; 1993 May; 15(5):287-91. PubMed ID: 8327287
[TBL] [Abstract][Full Text] [Related]
10. Aerosol alpha 1-antitrypsin treatment for cystic fibrosis.
McElvaney NG; Hubbard RC; Birrer P; Chernick MS; Caplan DB; Frank MM; Crystal RG
Lancet; 1991 Feb; 337(8738):392-4. PubMed ID: 1671425
[TBL] [Abstract][Full Text] [Related]
11. Revisiting alpha1-antitrypsin therapy in cystic fibrosis: can it still offer promise?
Brennan S
Eur Respir J; 2007 Feb; 29(2):229-30. PubMed ID: 17264320
[No Abstract] [Full Text] [Related]
12. Colistin stimulates the activity of neutrophil elastase and Pseudomonas aeruginosa elastase.
Jones A; Elphick H; Pettitt E; Everard ML; Evans GS
Eur Respir J; 2002 Jun; 19(6):1136-41. PubMed ID: 12108869
[TBL] [Abstract][Full Text] [Related]
13. Prolastin aerosol therapy and sputum taurine in cystic fibrosis.
Cantin AM; Berthiaume Y; Cloutier D; Martel M
Clin Invest Med; 2006 Aug; 29(4):201-7. PubMed ID: 16986483
[TBL] [Abstract][Full Text] [Related]
14. Effect of recombinant human DNase on alpha1-proteinase inhibitor function: an experimental approach to the combined clinical use of rhDNase and alpha1-PI in CF patients.
Hansen G; Hoffjan S; Mosler K; Schuster A
Lung; 2001; 179(3):185-94. PubMed ID: 11891608
[TBL] [Abstract][Full Text] [Related]
15. Effect of nebulised recombinant DNase on neutrophil elastase load in cystic fibrosis.
Costello CM; O'Connor CM; Finlay GA; Shiels P; FitzGerald MX; Hayes JP
Thorax; 1996 Jun; 51(6):619-23. PubMed ID: 8693445
[TBL] [Abstract][Full Text] [Related]
16. alpha1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients.
Griese M; Latzin P; Kappler M; Weckerle K; Heinzlmaier T; Bernhardt T; Hartl D
Eur Respir J; 2007 Feb; 29(2):240-50. PubMed ID: 17050563
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil elastase/alpha 1-proteinase inhibitor complex levels decrease in plasma of cystic fibrosis patients during long-term oral beta-carotene supplementation.
Winklhofer-Roob BM; Schlegel-Haueter SE; Khoschsorur G; van't Hof MA; Suter S; Shmerling DH
Pediatr Res; 1996 Jul; 40(1):130-4. PubMed ID: 8798258
[TBL] [Abstract][Full Text] [Related]
18. Proteinase/proteinase inhibitor imbalance in sputum sol phases from patients with chronic obstructive pulmonary disease. Suggestions for a key role played by antileukoprotease.
Piccioni PD; Kramps JA; Rudolphus A; Bulgheroni A; Luisetti M
Chest; 1992 Nov; 102(5):1470-6. PubMed ID: 1385052
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human Monocyte/Neutrophil elastase inhibitor protects rat lungs against injury from cystic fibrosis airway secretions.
Rees DD; Rogers RA; Cooley J; Mandle RJ; Kenney DM; Remold-O'Donnell E
Am J Respir Cell Mol Biol; 1999 Jan; 20(1):69-78. PubMed ID: 9870919
[TBL] [Abstract][Full Text] [Related]
20. Recombinant elastase inhibitors for therapy.
Schnebli HP
Ann N Y Acad Sci; 1991; 624():212-8. PubMed ID: 1676575
[No Abstract] [Full Text] [Related]
[Next] [New Search]